Medley, Inc. (TYO:4480)
Japan · Delayed Price · Currency is JPY 2,704.00
-35.00 (-1.28%)
Aug 26, 2026, 3:30 PM JST
Medley Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 41,004 | 36,786 | 29,302 | 20,532 | 14,185 | 10,863 |
Revenue Growth | 24.02% | 25.54% | 42.71% | 44.74% | 30.58% | 59.05% |
Gross Profit Gross Profit Growth | 25,510 | 23,186 | 18,920 | 13,587 | 9,721 | 6,985 |
Operating Income Operating Income Growth | 3,135 | 2,150 | 2,328 | 2,663 | 1,291 | 733 |
Net Income Net Income Growth | 1,825 | 975 | 2,798 | 2,566 | 1,017 | 563 |
Earnings Per Share EPS Growth | 58.92 | 30.47 | 85.62 | 78.55 | 31.16 | 17.15 |
EPS Growth | 33.60% | -64.41% | 9.00% | 152.09% | 81.69% | 18.44% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Platform Business Medical Platform Business Growth | 9,378 | 7,348 | 5,458 | 3,729 | 2,677 |
Human Resource Platform Business Human Resource Platform Business Growth | 26,321 | 21,108 | 14,656 | 10,131 | 7,879 |
New services New services Growth | 1,088 | 849 | 420 | 326 | 308.28 |
Unallocated Adjustment Unallocated Adjustment Growth | -2 | -4 | -2 | -2 | -0.2 |
Total Total Growth | 36,785 | 29,301 | 20,532 | 14,184 | 10,864 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12,042 | 8,575 | 18,996 | 15,354 | 14,422 | 14,294 |
Total Debt Total Debt Growth | 18,831 | 16,085 | 15,181 | 1,659 | 2,376 | 3,106 |
Net Cash (Debt) Net Cash Growth | -6,789 | -7,510 | 3,815 | 13,695 | 12,046 | 11,188 |
Net Cash Growth | - | - | -72.14% | 13.69% | 7.67% | 13.36% |
Net Cash Per Share Net Cash Per Share Growth | -219.21 | -234.58 | 116.73 | 419.15 | 368.80 | 340.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,883 | 3,486 | 2,447 | 3,871 | 2,013 | 1,038 |
Capital Expenditures CapEx Growth | -68 | -205 | -66 | -196 | -146 | -63 |
Free Cash Flow Free Cash Flow Growth | 4,815 | 3,281 | 2,381 | 3,675 | 1,867 | 975 |
Free Cash Flow Growth | 194.68% | 37.80% | -35.21% | 96.84% | 91.49% | 24.52% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.21% | 63.03% | 64.57% | 66.17% | 68.53% | 64.30% |
Operating Margin | 7.65% | 5.85% | 7.95% | 12.97% | 9.10% | 6.75% |
Pretax Margin | 8.18% | 6.47% | 13.88% | 18.51% | 10.74% | 7.03% |
Profit Margin | 4.45% | 2.65% | 9.55% | 12.50% | 7.17% | 5.18% |
FCF Margin | 11.74% | 8.92% | 8.13% | 17.90% | 13.16% | 8.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 46.49 | 75.14 | 44.52 | 55.36 | 124.04 | 133.16 |
Forward PE | 29.83 | 28.39 | 26.19 | 54.43 | 92.11 | 92.12 |
P/FCF Ratio | 17.19 | 22.33 | 52.32 | 38.65 | 67.57 | 76.89 |
PS Ratio | 2.02 | 1.99 | 4.25 | 6.92 | 8.89 | 6.90 |